These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6248790)
1. Lack of M-MuSV tumour regression associated with T lymphocyte tolerance. Chieco-Bianchi L; Collavo D; Zanovell P; De Rossi A; Davies AJ Nature; 1980 Jun; 285(5767):667-8. PubMed ID: 6248790 [No Abstract] [Full Text] [Related]
2. Immune reactivity in the Moloney strain of murine sarcoma virus oncogenesis: requirement of thymus-derived lymphocytes for in vivo protection. Collavo D; Colombatti A; Biasi G; Chieco-Bianchi L; Davies AJ J Natl Cancer Inst; 1976 Mar; 56(3):603-8. PubMed ID: 176399 [TBL] [Abstract][Full Text] [Related]
3. Appearance and distribution of virally determined antigens in lymphoid organs of mice during leukemogenesis by Moloney leukemia virus. Asjö B; Fenyö EM; Spira J; Klein G Leuk Res; 1980; 4(1):89-103. PubMed ID: 7412358 [No Abstract] [Full Text] [Related]
4. Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice. Takeichi N; Boone CW; Holden HT; Herberman RB Int J Cancer; 1978 Jan; 21(1):78-84. PubMed ID: 203543 [TBL] [Abstract][Full Text] [Related]
5. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors. Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385 [No Abstract] [Full Text] [Related]
6. Immunologic tolerance to antigens associated with murine leukemia viruses: T-cell unresponsiveness? Chieco-Bianchi L; Sendo F; Aoki T; Barrera OL J Natl Cancer Inst; 1974 Apr; 52(4):1345-50. PubMed ID: 4133203 [No Abstract] [Full Text] [Related]
7. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice. Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741 [TBL] [Abstract][Full Text] [Related]
8. Influence of Toxoplasma on manifestations of Moloney virus infections. McLeod R; Estes RG; Cohen H Trans R Soc Trop Med Hyg; 1985; 79(6):781-7. PubMed ID: 2938310 [TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility-restricted cytolytic T-lymphocyte precursors from the thymus of in vivo primed mice: increased frequency and resistance to anti-Lyt-2 antibody inhibition. Ceredig R Curr Top Microbiol Immunol; 1986; 126():27-33. PubMed ID: 3013506 [No Abstract] [Full Text] [Related]
11. T lymphocyte requirement for MSV tumour prevention or regression. Collavo D; Colombatti A; Chieco-Bianchi L Nature; 1974 May; 249(453):169-70. PubMed ID: 4545519 [No Abstract] [Full Text] [Related]
12. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV). Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521 [TBL] [Abstract][Full Text] [Related]
13. Tumor-enhancing suppressor activator T cells in spleens and thymuses of tumor immune mice. Hellström I; Hellström KE; Bernstein ID Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5294-8. PubMed ID: 315560 [TBL] [Abstract][Full Text] [Related]
14. Immunization against primary, transplanted and spontaneous murine leukaemia using a live Moloney sarcoma virus vaccine. Mayer AM; Basombrio MA; Pasqualini CD Br J Cancer; 1980 Jun; 41(6):966-75. PubMed ID: 6252923 [TBL] [Abstract][Full Text] [Related]
15. Genetic control of sensitivity to moloney leukemia virus in mice. VI. Involvement of virus-specific T helper cells collaborating with B cells. Boyer B; Debré P; Seman M; Zilberfarb V; Lévy JP Eur J Immunol; 1982 Aug; 12(8):692-7. PubMed ID: 6216112 [TBL] [Abstract][Full Text] [Related]